# MolBridge: Atom-Level Joint Graph Refinement for Robust Drug-Drug Interaction Event Prediction

arXiv: https://arxiv.org/abs/2510.20448 · HTML: https://mlsanity.com/paper/2510.20448/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Builds on 11 of its 38 references that are in the map.
- First posted on arXiv 23 Oct 2025.

## Builds on (most cited first, 11 of 11)

- [Semi-Supervised Classification with Graph Convolutional Networks](https://mlsanity.com/paper/1609.02907/) (2016)
- [Graph Attention Networks](https://mlsanity.com/paper/1710.10903/) (2017)
- [A Comprehensive Survey on Graph Neural Networks](https://mlsanity.com/paper/1901.00596/) (2019)
- [Modeling Relational Data with Graph Convolutional Networks](https://mlsanity.com/paper/1703.06103/) (2017)
- [Composition-based Multi-Relational Graph Convolutional Networks](https://mlsanity.com/paper/1911.03082/) (2019)
- [Multi-view Graph Contrastive Representation Learning for Drug-Drug Interaction Prediction](https://mlsanity.com/paper/2010.11711/) (2020)
- [SumGNN: Multi-typed Drug Interaction Prediction via Efficient Knowledge Graph Summarization](https://mlsanity.com/paper/2010.01450/) (2020)
- [Drug-Drug Interaction Prediction Based on Knowledge Graph Embeddings and Convolutional-LSTM Network](https://mlsanity.com/paper/1908.01288/) (2019)
- [GoGNN: Graph of Graphs Neural Network for Predicting Structured Entity Interactions](https://mlsanity.com/paper/2005.05537/) (2020)
- [Emerging Drug Interaction Prediction Enabled by Flow-based Graph Neural Network with Biomedical Network](https://mlsanity.com/paper/2311.09261/) (2023)
- [Learning to Denoise Biomedical Knowledge Graph for Robust Molecular Interaction Prediction](https://mlsanity.com/paper/2312.06682/) (2023)

## Abstract (arXiv)

Drug combinations offer therapeutic benefits but also carry the risk of adverse drug-drug interactions (DDIs), especially under complex molecular structures. Accurate DDI event prediction requires capturing fine-grained inter-drug relationships, which are critical for modeling metabolic mechanisms such as enzyme-mediated competition. However, existing approaches typically rely on isolated drug representations and fail to explicitly model atom-level cross-molecular interactions, limiting their effectiveness across diverse molecular complexities and DDI type distributions. To address these limitations, we propose MolBridge, a novel atom-level joint graph refinement framework for robust DDI event prediction. MolBridge constructs a joint graph that integrates atomic structures of drug pairs, enabling direct modeling of inter-drug associations. A central challenge in such joint graph settings is the potential loss of information caused by over-smoothing when modeling long-range atomic dependencies. To overcome this, we introduce a structure consistency module that iteratively refines node features while preserving the global structural context. This joint design allows MolBridge to effectively learn both local and global interaction outperforms state-of-the-art baselines, achieving superior performance across long-tail and inductive scenarios. patterns, yielding robust representations across both frequent and rare DDI types. Extensive experiments on two benchmark datasets show that MolBridge consistently. These results demonstrate the advantages of fine-grained graph refinement in improving the accuracy, robustness, and mechanistic interpretability of DDI event prediction.This work contributes to Web Mining and Content Analysis by developing graph-based methods for mining and analyzing drug-drug interaction networks.